Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.
Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA. Lee IH, et al. Among authors: lee kh, lee sa, lee jl. Korean J Intern Med. 2020 Jan;35(1):185-193. doi: 10.3904/kjim.2018.064. Epub 2018 Oct 12. Korean J Intern Med. 2020. PMID: 30301310 Free PMC article.
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.
Park S, Kang BW, Lee SJ, Yoon S, Chae YS, Kim JG, Lee KH, Koh SA, Song HS, Park KU, Kim JY, Heo MH, Ryoo HM, Cho YY, Jo J, Lee JL, Lee SA. Park S, et al. Among authors: lee sj, lee kh, lee sa, lee jl. Cancer Chemother Pharmacol. 2017 Jul;80(1):187-193. doi: 10.1007/s00280-017-3348-z. Epub 2017 Jun 8. Cancer Chemother Pharmacol. 2017. PMID: 28597039
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer.
Park IH, Sohn JH, Kim SB, Lee KS, Chung JS, Lee SH, Kim TY, Jung KH, Cho EK, Kim YS, Song HS, Seo JH, Ryoo HM, Lee SA, Yoon SY, Kim CS, Kim YT, Kim SY, Jin MR, Ro J. Park IH, et al. Among authors: lee sh, lee ks, lee sa. Cancer Res Treat. 2017 Jul;49(3):569-577. doi: 10.4143/crt.2016.289. Epub 2016 Sep 12. Cancer Res Treat. 2017. PMID: 27618821 Free PMC article. Clinical Trial.
Thalidomide for POEMS syndrome.
Kim SY, Lee SA, Ryoo HM, Lee KH, Hyun MS, Bae SH. Kim SY, et al. Among authors: lee kh, lee sa. Ann Hematol. 2006 Aug;85(8):545-6. doi: 10.1007/s00277-006-0119-z. Epub 2006 May 23. Ann Hematol. 2006. PMID: 16718498 No abstract available.
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.
Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Lee HS, Yun HJ, Lee SI, Kim MK, Yi JH, Lee JH, Kim WS, Suh C. Hong J, et al. Oncotarget. 2017 Sep 18;8(54):92171-92182. doi: 10.18632/oncotarget.20988. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190906 Free PMC article.
2,041 results